Breo Ellipta: Understanding Your Inhaler for Asthma and COPD

Breo Ellipta, a prescription medication, is a vital tool for managing chronic obstructive pulmonary disease (COPD) and asthma. It is administered through an inhaler, delivering its active ingredients directly to the lungs. This blog post aims to provide a comprehensive understanding of Breo Ellipta, covering its uses, dosages, potential side effects, and important considerations for patients in India.

What is Breo Ellipta?

Breo Ellipta is a combination medication containing two active ingredients: fluticasone furoate and vilanterol. Fluticasone furoate is a corticosteroid that works by reducing inflammation in the airways, while vilanterol is a long-acting beta-agonist (LABA) that helps to relax the muscles around the airways, making breathing easier. It is available under the brand name Breo Ellipta and does not currently have a generic version.

It is crucial to understand that Breo Ellipta is not a rescue inhaler. It is designed for the long-term management and prevention of symptoms associated with COPD and asthma, not for immediate relief of sudden breathing difficulties.

Uses of Breo Ellipta

Breo Ellipta is prescribed for two primary respiratory conditions:

• Chronic Obstructive Pulmonary Disease (COPD): In adults, it is used to prevent symptoms of COPD, a progressive lung disease that makes breathing difficult.
• Asthma: It is used to manage asthma in adults and certain children (aged 5 years and older). It helps to control asthma symptoms and prevent exacerbations.

Dosage and Administration

The dosage of Breo Ellipta is determined by the doctor based on the patient's condition, age, and severity of symptoms. The medication is inhaled once daily using the Ellipta inhaler. Common available strengths include:

• Fluticasone furoate 50 micrograms (mcg)/vilanterol 25 mcg
• Fluticasone furoate 100 mcg/vilanterol 25 mcg
• Fluticasone furoate 200 mcg/vilanterol 25 mcg

Typical Dosages:

1. For COPD in adults: The usual dose is 100 mcg/25 mcg inhaled once daily.
2. For Asthma in adults: Patients may be prescribed either 100 mcg/25 mcg or 200 mcg/25 mcg inhaled once daily.
3. For Asthma in children (12–17 years): The recommended dose is 100 mcg/25 mcg inhaled once daily.
4. For Asthma in children (5–11 years): The recommended dose is 50 mcg/25 mcg inhaled once daily.

It is vital to use Breo Ellipta exactly as prescribed by your doctor and to follow the instructions for using the Ellipta inhaler carefully. Do not stop using the medication or change the dosage without consulting your doctor.

Potential Side Effects

Like all medications, Breo Ellipta can cause side effects, ranging from mild to serious. It's important to be aware of these potential effects.

Common Mild Side Effects:

These side effects are generally temporary and may resolve within a few days or weeks. If they become bothersome, consult your doctor or pharmacist.

• Upper respiratory infections (common cold symptoms)
• Yeast infections in the mouth or throat (thrush)

Serious Side Effects:

While less common, serious side effects can occur. Seek immediate medical attention if you experience any of the following:

• Increased risk of serious infections: Such as pneumonia or measles. Patients with weakened immune systems are at higher risk.
• Heart problems: Including high blood pressure or changes in heart rhythm.
• Low bone density: This can increase the risk of fractures over time.
• Trouble breathing: Immediately after inhaling a dose.
• Allergic reactions: Symptoms can range from mild flushing to severe reactions like difficulty breathing, rash, itching, or swelling of the face, tongue, or throat. If you suspect an allergic reaction, call your doctor immediately or seek emergency medical help.

It is essential to discuss any pre-existing health conditions, such as heart disease, high blood pressure, or a weakened immune system, with your doctor before starting Breo Ellipta.

When to Consult a Doctor

You should consult your doctor immediately if:

• You experience any signs of a serious side effect, including severe breathing difficulties, chest pain, or symptoms of a severe allergic reaction.
• You develop signs of an infection, such as fever, chills, or persistent cough.
• Your asthma or COPD symptoms do not improve or worsen despite using Breo Ellipta.
• You have concerns about the medication or its side effects.

In case of a medical emergency, such as severe shortness of breath or signs of a severe allergic reaction, call 108 (India's emergency number) or go to the nearest hospital emergency room immediately.

Overdose

If you suspect you have taken too much Breo Ellipta, contact your doctor or a poison control center immediately. If you experience severe symptoms, call emergency services or go to the nearest emergency room.

Prevention and Management Tips

• Proper Inhaler Technique: Ensure you are using the Ellipta inhaler correctly. Your doctor or pharmacist can demonstrate the proper technique.
• Oral Hygiene: Rinse your mouth with water after using the inhaler to help prevent oral yeast infections.
• Regular Check-ups: Attend all scheduled doctor's appointments to monitor your condition and the effectiveness of the medication.
• Avoid Triggers: Identify and avoid personal triggers for asthma or COPD, such as smoke, pollution, or allergens.
• Healthy Lifestyle: Maintain a balanced diet and engage in regular, appropriate physical activity as advised by your doctor.

Breo Ellipta is a valuable medication for managing chronic respiratory conditions. By understanding its uses, dosages, and potential side effects, and by working closely with your healthcare provider, you can effectively manage your condition and improve your quality of life.